The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Suppression of poly-ADP ribose (PAR) levels in PBMCs by veliparib (vel) as a pharmacodynamic (PD) marker associated with survival among women with BRCA1- or BRCA2- (BRCA)-associated metastatic breast cancer (MBC).
 
Jeffrey N. Weitzel
No Relationships to Disclose
 
Paul Henry Frankel
No Relationships to Disclose
 
Josef Herzog
No Relationships to Disclose
 
Banu Arun
Consulting or Advisory Role - Abbvie
Research Funding - Avon Foundation; Susan G. Komen for the Cure
 
Jan Hendrik Beumer
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - BTG
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Millennium (Inst); Novartis (Inst); Saladax Biomedical (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
 
Cynthia X. Ma
Consulting or Advisory Role - Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Tessa Cigler
Honoraria - Novartis
Speakers' Bureau - Novartis
 
Leah Cream
No Relationships to Disclose
 
Harold A. Harvey
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); Janssen (Inst); Tercica (Inst)
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - AstraZeneca; Celgene; Curis; Eisai; Genentech/Roche; Johnson & Johnson; Novartis; Sanofi
Research Funding - Merck (Inst)
 
Rita Nanda
No Relationships to Disclose
 
Helen K. Chew
No Relationships to Disclose
 
Linda T. Vahdat
No Relationships to Disclose
 
Matthew P. Goetz
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Lilly
 
David R. Gandara
Honoraria - Array BioPharma; AstraZeneca; Celgene; Lilly; Novartis; Synta
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Response Genetics; Sanofi; Synta
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biomarin; Boehringer Ingelheim; Dava Oncology; Pfizer
 
Richard Piekarz
No Relationships to Disclose
 
Lily Ravel Van Tongeren
No Relationships to Disclose
 
Katherine V. Ferry-Galow
Stock and Other Ownership Interests - Johnson & Johnson
 
Timothy W. Synold
Consulting or Advisory Role - Novartis
 
George Somlo
Other Relationship - Abbvie